Editorial: Hepatocellular Carcinoma
A bridge between multi-omics data and the management of hepatocellular carcinoma
Annals of Translational Medicine
2015;
3
(1)
:1
.
(12 January 2015)
Multi-omics in prognosis of hepatocellular carcinoma
Annals of Translational Medicine
2015;
3
(1)
:2
.
(12 January 2015)
Comprehensive characterization of hepatitis B virus-associated multifocal hepatocellular carcinoma using a multi-omics strategy
Annals of Translational Medicine
2015;
3
(1)
:3
.
(12 January 2015)
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?
Annals of Translational Medicine
2015;
3
(1)
:4
.
(12 January 2015)
Review Article
Recent advances in the development of farnesoid X receptor agonists
Annals of Translational Medicine
2015;
3
(1)
:5
.
(12 January 2015)
Osteonecrosis of the knee: review
Annals of Translational Medicine
2015;
3
(1)
:6
.
(12 January 2015)
Advances and challenges in the molecular biology and treatment of glioblastoma—is there any hope for the future?
Annals of Translational Medicine
2015;
3
(1)
:7
.
(12 January 2015)
Cardiovascular disease in systemic sclerosis
Annals of Translational Medicine
2015;
3
(1)
:8
.
(12 January 2015)
Helicobacter Pylori
Diagnosis of Helicobacter pylori using the rapid urease test
Annals of Translational Medicine
2015;
3
(1)
:9
.
(12 January 2015)
Diagnosis of Helicobacter pylori by invasive test: histology
Annals of Translational Medicine
2015;
3
(1)
:10
.
(12 January 2015)
Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination
Annals of Translational Medicine
2015;
3
(1)
:11
.
(12 January 2015)
Stereotactic Ablative Radiotherapy
Stereotactic ablative radiotherapy: aim for a cure of cancer
Annals of Translational Medicine
2015;
3
(1)
:12
.
(12 January 2015)
Meet the Professor1
Prof. Weihai Xu: 3D intracranial artery printing transforms the future of stroke
Annals of Translational Medicine
2015;
3
(1)
:13
.
(12 January 2015)
Disclosure:
1. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.
